Search filters

List of works by Laura Biganzoli

3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3).

scientific article published on 19 February 2017

3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3).

scientific article

3rd ESO-ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3).

scientific article

4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)†

scientific article published on 01 August 2018

A Randomized Placebo-Controlled Phase 2 Trial Evaluating Exemestane With or Without Enzalutamide in Patients With Hormone Receptor-positive Breast Cancer

scientific article published on 28 September 2020

A dose-finding study of lanreotide (a somatostatin analog) in patients with colorectal carcinoma

scientific article published on 01 July 1996

A gene expression signature of Retinoblastoma loss-of-function predicts resistance to neoadjuvant chemotherapy in ER-positive/HER2-positive breast cancer patients

scientific article published on 22 March 2018

A joined analysis of two European Organization for the Research and Treatment of Cancer (EORTC) studies to evaluate the role of pegylated liposomal doxorubicin (Caelyx) in the treatment of elderly patients with metastatic breast cancer

scientific article published on 20 November 2006

A prognostic factor index for overall survival in patients receiving first-line chemotherapy for HER2-negative advanced breast cancer: an analysis of the ATHENA trial.

scientific article

ASCO 2009: What's New in Breast Cancer Therapy?

scientific article

About the French prohibition of textured breast implants: is it justified or over-cautious? The EUSOMA, ESSO/BRESSO position

scientific article published on 03 May 2019

Adherence to oral cancer therapy in older adults: The International Society of Geriatric Oncology (SIOG) taskforce recommendations.

scientific article

Adjuvant Systemic Therapy in Older Breast Cancer Women: Can We Optimize the Level of Care?

scientific article

Adjuvant chemotherapy in elderly patients with breast cancer: a survey of the Breast International Group (BIG).

scientific article published in February 2004

Adjuvant chemotherapy--the dark side of clinical trials. Have we learnt more?

scientific article published on October 2009

Adjuvant endocrine therapy in premenopausal patients with hormone receptor-positive early breast cancer: Evidence evaluation and GRADE recommendations by the Italian Association of Medical Oncology (AIOM)

article

Adjuvant systemic therapy for breast cancer

scientific article published on 01 November 1996

Adjuvant therapy in elderly patients with breast cancer.

scientific article published in August 2004

An EORTC phase I study of capecitabine (Xeloda) in combination with fixed doses of cyclophosphamide and epirubicin (cex) as primary treatment for large operable or locally advanced/inflammatory breast cancer.

scientific article published in June 2003

An EORTC phase I study of epirubicin in combination with fixed doses of cyclophosphamide and infusional 5-fu (CEF-infu) as primary treatment of large operable or locally advanced/inflammatory breast cancer ⬇️

scientific article published on November 1, 2001

An EORTC-IDBBC phase I study of gemcitabine and continuous infusion 5-fluorouracil in patients with metastatic breast cancer resistant to anthracyclines or pre-treated with both anthracyclines and taxanes.

scientific article

An I.T.M.O. group study on second-line treatment in advanced epithelial ovarian cancer: an attempt to identify clinical and biological factors determining prognosis

scientific article published on 01 December 1995

An Italian Delphi study to evaluate consensus on adjuvant endocrine therapy in premenopausal patients with breast cancer: the ERA project

article

An intensive treatment with mitoxantrone and ifosfamide in second-line therapy of epithelial ovarian cancer

scientific article published on 01 December 1994

Baseline health-related quality-of-life data as prognostic factors in a phase III multicentre study of women with metastatic breast cancer.

scientific article

Breast cancer in the elderly: which lessons have we learned?

scientific article

Breast cancer therapies in development. A review of their pharmacology and clinical potential.

scientific article

Carboplatin in patients with advanced colorectal cancer pretreated with fluoropyrimidines

scientific article published on 01 January 1993

Cardiac safety, efficacy, and correlation of serial serum HER2-extracellular domain shed antigen measurement with the outcome of the combined trastuzumab plus CMF in women with HER2-positive metastatic breast cancer: results from the EORTC 10995 pha

scientific article published on 21 March 2017

Challenges in the management of advanced, ER-positive, HER2-negative breast cancer

scientific article published on 26 May 2015

Chemotherapy for metastatic breast cancer.

scientific article published on February 2004

Chemotherapy with or without trastuzumab.

scientific article published on October 2010

Clinical outcome of breast cancer patients with liver metastases alone in the anthracycline-taxane era: a retrospective analysis of two prospective, randomised metastatic breast cancer trials ⬇️

scientific article published on November 1, 2003

Clinical outcomes after palbociclib with or without endocrine therapy in postmenopausal women with hormone receptor positive and HER2-negative metastatic breast cancer enrolled in the TREnd trial.

scientific article

Combination goserelin and tamoxifen therapy in premenopausal advanced breast cancer: a multicentre study by the ITMO group. Italian Trials in Medical Oncology

scientific article

Continued value of adjuvant anthracyclines as treatment for early breast cancer.

scientific article published on July 2015

Control of emesis by a low dose of ondansetron and dexamethasone

scientific article published on 01 April 1994

Controversial issues in the management of older adults with early breast cancer.

scientific article published on 08 June 2017

Controversies in the adjuvant treatment of breast cancer: the role of taxanes.

scientific article published in January 2004

Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients.

scientific article

Corrigendum to "3rd ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 3)" [Breast 31 (February 2017) 244-259].

scientific article published on 18 January 2017

Cyclin-Dependent Kinase 4/6 Inhibitors in Neoadjuvant Endocrine Therapy of Hormone Receptor-Positive Breast Cancer

scientific article published on 11 June 2019

De-escalating and escalating treatment beyond endocrine therapy in patients with luminal breast cancer.

scientific article

Defining optimal duration and predicting benefit from chemotherapy in patients with luminal-like subtypes

scientific article published on 27 August 2015

Demographic, tumor and clinical features of clinical trials versus clinical practice patients with HER2-positive early breast cancer: results of a prospective study.

scientific article published on 25 August 2015

Doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: The European Organization for Research and Treatment of Cancer 10961 Multicenter Phase III Trial

scientific article published on 01 July 2002

Doxorubicin-paclitaxel: a safe regimen in terms of cardiac toxicity in metastatic breast carcinoma patients. Results from a European Organization for Research and Treatment of Cancer multicenter trial

scientific article published on 01 January 2003

EFFECT: a randomized phase II study of efficacy and impact on function of two doses of nab-paclitaxel as first-line treatment in older women with advanced breast cancer

scientific article published on 05 August 2020

EORTC Cancer in the Elderly Task Force guidelines for the use of colony-stimulating factors in elderly patients with cancer ⬇️

scientific article published on November 1, 2003

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2).

scientific article

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†

scientific article

EUSOMA position regarding breast implant associated anaplastic large cell lymphoma (BIA-ALCL) and the use of textured implants

scientific article published on 26 January 2019

Early triple negative breast cancer: Are we getting better outcomes? A retrospective analysis from a single institution

scientific article published on 16 July 2019

Elderly breast cancer patients: adjuvant chemotherapy and adjuvant endocrine therapy

scientific article published on 01 June 2005

Epirubicin plus medroxyprogesterone as second-line treatment of advanced prostatic cancer. A study by the Italian Trials in Medical Oncology Group.

scientific article published on June 1995

Eribulin Mesylate as Third or Subsequent Line Chemotherapy for Elderly Patients with Locally Recurrent or Metastatic Breast Cancer: A Multicentric Observational Study of GIOGer (Italian Group of Geriatric Oncology)-ERIBE

article

Estimating the risk of chemotherapy toxicity in older patients with cancer: The role of the Vulnerable Elders Survey-13 (VES-13).

scientific article published on 15 June 2015

Evaluation of the cardiovascular health study (CHS) instrument and the Vulnerable Elders Survey-13 (VES-13) in elderly cancer patients. Are we still missing the right screening tool?

scientific article published on 7 October 2012

Evaluation of tumor response, disease control, progression-free survival, and time to progression as potential surrogate end points in metastatic breast cancer.

scientific article published in April 2008

Feasibility and safety of dose-dense docetaxel after conventional epirubicin and cyclophosphamide as adjuvant treatment for early breast cancer patients.

scientific article published on 22 May 2013

Final overall survival results and effect of prolonged (≥ 1 year) first-line bevacizumab-containing therapy for metastatic breast cancer in the ATHENA trial

scientific article published on 10 August 2011

Final results of a multicenter phase II clinical trial evaluating the activity of single-agent lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells. A proof-of-concept study

scientific article published on 4 April 2012

First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2,251 patients.

scientific article published on 5 September 2010

First-line bevacizumab-containing therapy for triple-negative breast cancer: analysis of 585 patients treated in the ATHENA study

scientific article published on 12 April 2012

Glutamine supplementation in cancer patients receiving chemotherapy: a double-blind randomized study

scientific article published on 01 July 1997

HER2-positive metastatic breast cancer: a changing scenario

scientific article

HER2-targeted treatment for older patients with breast cancer: An expert position paper from the International Society of Geriatric Oncology

scientific article published on 22 June 2019

Hormone therapy in advanced breast carcinoma: present and future trends.

scientific article published on July 1994

Identification of a serum-detectable metabolomic fingerprint potentially correlated with the presence of micrometastatic disease in early breast cancer patients at varying risks of disease relapse by traditional prognostic methods

scientific article published on 03 January 2011

Inclusion of Platinum Agents in Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer Patients: Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) Recommendation by the Italian Association of Medica

scientific article published on 08 August 2019

Inter- and intra-tumoral heterogeneity in DNA damage evaluated by comet assay in early breast cancer patients

scientific article published on 08 March 2012

Is There Still a Role for First-Line Single Agent Endocrine Therapy in HR+ and HER2- Advanced Breast Cancer?

scientific article

Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology

scientific article published on December 2007

Managing advanced HR-positive, HER2-negative breast cancer with CDK4/6 inhibitors in post-menopausal patients: is there a best sequence?

scientific article published on 10 December 2018

Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer.

scientific article published in September 2003

Metabolomic analysis of serum may refine 21-gene expression assay risk recurrence stratification

scientific article published on 29 August 2019

Metabolomics in breast cancer: A decade in review

article

Metabolomics: available results, current research projects in breast cancer, and future applications.

scientific article

Mitoxantrone and ifosfamide as second-line therapy of epithelial ovarian cancer. A pilot study by the I.T.M.O. Group

scientific article published on 01 January 1994

New strategies to identify molecular markers predicting chemotherapy activity and toxicity in breast cancer.

scientific article published on December 2007

No pain, no gain… What we can learn from a trial reporting negative results

scientific article published on 01 April 2017

Nutritional management of older adults with gastrointestinal cancers: An International Society of Geriatric Oncology (SIOG) review paper.

scientific article published on 22 January 2018

Optimizing taxane use in MBC in the emerging era of targeted chemotherapy ⬇️

scientific article published on October 30, 2012

Oral doxifluridine plus levoleucovorin in elderly patients with advanced breast cancer

scientific article published on 01 September 1998

Oral single-agent chemotherapy in older patients with solid tumours: A position paper from the International Society of Geriatric Oncology (SIOG).

scientific article published on September 2015

Paclitaxel versus doxorubicin as first-line single-agent chemotherapy for metastatic breast cancer: a European Organization for Research and Treatment of Cancer Randomized Study with cross-over

scientific article published on 01 February 2000

Palbociclib as single agent or in combination with the endocrine therapy received before disease progression for estrogen receptor-positive, HER2-negative metastatic breast cancer: TREnd trial

scientific article published on 01 August 2018

Pembrolizumab plus trastuzumab in trastuzumab-resistant, advanced, HER2-positive breast cancer (PANACEA): a single-arm, multicentre, phase 1b-2 trial

scientific article published on 11 February 2019

Phase 1B/2 study of the HSP90 inhibitor AUY922 plus trastuzumab in metastatic HER2-positive breast cancer patients who have progressed on trastuzumab-based regimen

scientific article published on 25 April 2016

Phase II study of vinorelbine in patients with pretreated advanced ovarian cancer: activity in platinum-resistant disease

scientific article published on 01 September 1996

Platinum-based Agent and Fluorouracil in Metastatic Breast Cancer: A Retrospective Monocentric Study with a Review of the Literature

scientific article published on 01 August 2018

Predictive molecular markers in the adjuvant therapy of breast cancer: state of the art in the year 2002.

scientific article

Prognostic and predictive factors.

scientific article

Prognostic role of serum thymidine kinase 1 activity in patients with hormone receptor-positive metastatic breast cancer: Analysis of the randomised phase III Evaluation of Faslodex versus Exemestane Clinical Trial (EFECT)

scientific article published on 03 May 2019

Quality indicators in breast cancer care

scientific article published on 31 July 2010

Quality indicators in breast cancer care: An update from the EUSOMA working group

scientific article

Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial

scientific article published on 10 April 2019

Randomized, controlled trial investigating short-term health-related quality of life with doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: European Organization f

article

Recent advances in systemic therapy: new diagnostics and biological predictors of outcome in early breast cancer.

scientific article published on 03 April 2009

Safety and efficacy of bevacizumab in combination with first-line chemotherapy in advanced breast cancer: data from the Italian cohort of the ATHENA trial.

scientific article

Screening for Frailty in Older Patients With Early-Stage Solid Tumors: A Prospective Longitudinal Evaluation of Three Different Geriatric Tools

scientific article published on 2 February 2017

Selection of chemotherapeutic drugs in adjuvant programs based on molecular profiles: where do we stand?

scientific article published on 21 February 2007

Serum Metabolomic Profiles Identify ER-Positive Early Breast Cancer Patients at Increased Risk of Disease Recurrence in a Multicenter Population

scientific article published on 12 January 2017

Taxanes alone or in combination with anthracyclines as first-line therapy of patients with metastatic breast cancer.

scientific article published in April 2008

The best treatment for older patients with breast cancer.

scientific article

The bigger the better? ... or what we know and what we still need to learn about anthracycline dose per course, dose density and cumulative dose in the treatment of breast cancer

scientific article published on 01 December 1997

The continued evidence from overviews: what is the clinical utility?

scientific article published on August 2013

The impact of chemotherapy dose density and dose intensity on breast cancer outcome: what have we learned?

scientific article

The intramuscular administration of granulocyte colony-stimulating factor as an adjunct to chemotherapy in pretreated ovarian cancer patients: an Italian Trials in Medical Oncology (ITMO) Group pilot study.

scientific article

The optimal duration of adjuvant endocrine therapy in early luminal breast cancer: A concise review

scientific article published on 25 January 2019

The role of abemaciclib in treatment of advanced breast cancer.

scientific article published on 31 May 2018

Thyroid cancer: different outcomes to chemotherapy according to tumour histology

scientific article published on 01 December 1995

Topoisomerase II alpha as a marker predicting anthracyclines' activity in early breast cancer patients: ready for the primetime?

scientific article

Toxicity profile differences of adjuvant docetaxel/cyclophosphamide (TC) between Asian and Caucasian breast cancer patients

scientific article

Trends in axillary lymph node dissection for early-stage breast cancer in Europe: Impact of evidence on practice

scientific article published on 11 March 2019

Using specific cytotoxics with a targeted mind.

scientific article published on 27 August 2007

Utility of gonadotropin-releasing hormone agonists for fertility preservation in young breast cancer patients: the benefit remains uncertain ⬇️

scientific article published on May 24, 2013

Variability in breast cancer surgery training across Europe: An ESSO-EUSOMA international survey

scientific article published on 05 January 2019

Paulina is supported by:

About Paulina

Help